Citric acid monohydrate 5949-29-1 99%
Shanghai, Run-Biotech Co., Ltd is a leading domestic pharmaceutical, biopharmaceutical, and health care products R & D outsourcing services company. As an innovation-driven and customer-focused company, Run Biotech provides a broad and integrated portfolio of services throughout the drug R&D process. Our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient outsourcing solutions.
Based on our technical expertise and excellent research facilities, we successfully establish facilities, advanced R & D services technology platform. We will achieve leapfrog all-round development in the field of chemical synthesis, medicinal chemistry, biological and so on.
Run Biotech has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, discovery biology, pharmacology, formulation services, biologics manufacturing services, antibody, biological research reagent manufacturing and sales services.
In Taiwan , Mainland China and Southeast Asia, Run Biotech has its own logistics center, provides the professional, personalized one-stop services, offers a variety of technologies and products and services for the world's major technology and industrial customers.
Citric acid monohydrate Basic information |
Citric acid monohydrate Chemical Properties |
Melting point | -94 °C(lit.) |
Boiling point | 56 °C760 mm Hg(lit.) |
density | 0.791 g/mL at 25 °C(lit.) |
vapor density | 2 (vs air) |
vapor pressure | 184 mm Hg ( 20 °C) |
refractive index |
n |
Fp | 1 °F |
storage temp. | Store at RT. |
solubility | H2O: soluble54% (w/w) at 10°C (Citric acid in water) |
form | Solid |
color | White |
Specific Gravity | 0.810 (20/4℃) |
PH | 1.85 (50g/l, H2O, 25℃) |
Water Solubility | 1630 g/L (20 ºC) |
Sensitive | Hygroscopic |
Merck | 14,2326 |
BRN | 4018641 |
Stability: | Stable. Incompatible with oxidizing agents, bases, reducing agents, nitrates. |
InChIKey | YASYEJJMZJALEJ-UHFFFAOYSA-N |
CAS DataBase Reference | 5949-29-1(CAS DataBase Reference) |
NIST Chemistry Reference | Citric acid monohydrate(5949-29-1) |
Safety Information |
Hazard Codes | F,Xi |
Risk Statements | 11-36-66-67-41-36/37/38-37/38 |
Safety Statements | 9-16-26-37/39-36/37/39-36 |
RIDADR | UN 1090 3/PG 2 |
WGK Germany | 1 |
RTECS | AL3150000 |
TSCA | Yes |
HS Code | 29181400 |
Toxicity | LD50 orally in Rabbit: 3000 mg/kg |
MSDS Information |
Provider | Language |
---|---|
Citric acid monohydrate | English |
SigmaAldrich | English |
ALFA | English |
Citric acid monohydrate Usage And Synthesis |
Chemical Properties | white crystals or powder |
Chemical Properties | Citric acid monohydrate occurs as colorless or translucent crystals, or as a white crystalline, efflorescent powder. It is odorless and has a strong acidic taste. The crystal structure is orthorhombic. |
Production Methods | Citric acid occurs naturally in a number of plant species and may be extracted from lemon juice, which contains 5–8% citric acid, or pineapple waste. Anhydrous citric acid may also be produced industrially by mycological fermentation of crude sugar solutions such as molasses, using strains of Aspergillus niger . Citric acid is purified by recrystallization; the anhydrous form is obtained from a hot concentrated aqueous solution and the monohydrate from a cold concentrated aqueous solution. |
Pharmaceutical Applications |
Citric acid (as either the monohydrate or anhydrous material) is widely used in pharmaceutical formulations and food products, primarily to adjust the pH of solutions. It has also been used experimentally to adjust the pH of tablet matrices in enteric-coated formulations for colon-specific drug delivery. Citric acid monohydrate is used in the preparation of effervescent granules, while anhydrous citric acid is widely used in the preparation of effervescent tablets. Citric acid has also been shown to improve the stability of spray-dried insulin powder in inhalation formulations. In food products, citric acid is used as a flavor enhancer for its tart, acidic taste. Citric acid monohydrate is used as a sequestering agent and antioxidant synergist. It is also a component of anticoagulant citrate solutions. Therapeutically, preparations containing citric acid have been used to dissolve renal calculi. |
Safety |
Citric acid is found naturally in the body, mainly in the bones, and is commonly consumed as part of a normal diet. Orally ingested citric acid is absorbed and is generally regarded as a nontoxic material when used as an excipient. However, excessive or frequent consumption of citric acid has been associated with erosion of the teeth. Citric acid and citrates also enhance intestinal aluminum absorption in renal patients, which may lead to increased, harmful serum aluminum levels. It has therefore been suggested that patients with renal failure taking aluminum compounds to control phosphate absorption should not be prescribed citric acid or citrate-containing products. |
storage | Citric acid monohydrate loses water of crystallization in dry air or when heated to about 408℃. It is slightly deliquescent in moist air. Dilute aqueous solutions of citric acid may ferment on standing. |
Purification Methods | Crystallise it from hot H2O solution (w/w solubility is 54% at 10o, 71% at 50o and 84% at 100o. The monohydrate (softens at ~75o and melts at ~100o) dehydrates in air or when heated gently above 40o . The triethylester ( M 276.3, b 127o/1mm, 294o/atm, d 4 1.137, n D 1.4420.) is a bitter tasting oil. [Beilstein 3 H 556 and 568, 3 IV 1272.] |
Incompatibilities | Citric acid is incompatible with potassium tartrate, alkali and alkaline earth carbonates and bicarbonates, acetates, and sulfides. Incompatibilities also include oxidizing agents, bases, reducing agents, and nitrates. It is potentially explosive in combination with metal nitrates. On storage, sucrose may crystallize from syrups in the presence of citric acid. |
Regulatory Status | GRAS listed. The anhydrous form is accepted for use as a food additive in Europe. Included in the FDA Inactive Ingredients Database (inhalations; IM, IV, and other injections; ophthalmic preparations; oral capsules, solutions, suspensions and tablets; topical and vaginal preparations). Included in nonparenteral and parenteral medicines licensed in Japan and the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients. |
Citric acid monohydrate Preparation Products And Raw materials |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View